Capstan Therapeutics

📍 San Diego, United States🗓 Founded 2021👥 31 employees💰 Last funded Mar 2024
Biotechnology Research🌐 abbvie.com
Website LinkedIn
Capstan Therapeutics is now part of AbbVie. AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance peoples lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need. For more information about AbbVie, please visit us at www.abbvie.com. Follow AbbVie on LinkedIn for future updates. 
2
Total investors
1
Early stage
1
Mid stage
0
Late stage
2021
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Capstan Therapeutics?
Capstan Therapeutics has 2 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage.
When did Capstan Therapeutics last raise funding?
The most recent investment in Capstan Therapeutics recorded on gritt.io was in March 2024.
When was Capstan Therapeutics founded?
Capstan Therapeutics was founded in 2021.
What industry is Capstan Therapeutics in?
Capstan Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Capstan Therapeutics based?
Capstan Therapeutics is headquartered in San Diego, United States.